Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (Nature Medicine, (2021), 27, 2, (279-288), 10.1038/s41591-020-01179-4)

the Oxford COVID Vaccine Trial Group

doi:10.1038/s41591-021-01372-z

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (Nature Medicine, (2021), 27, 2, (279-288), 10.1038/s41591-020-01179-4)

the Oxford COVID Vaccine Trial Group

Research output: Contribution to journal › Comment/debate

9 Citations (Scopus)

Abstract

In the version of this article initially published, the numbers of cells in the third sentence of the second paragraph of the Methods subsection ‘Antibody-dependent neutrophil phagocytosis’ (500,000) and in the fifth sentence of the first paragraph of the Methods subsection ‘Antibody-dependent monocyte phagocytosis’ (250,000) were incorrect. The correct numbers are 50,000 and 25,000 (respectively). The errors have been corrected in the HTML and PDF versions of the article. *A full list of authors and their affiliations appears at the end of the paper.

Original language	English
Pages (from-to)	1113
Number of pages	1
Journal	Nature Medicine
Volume	27
Issue number	6
DOIs	https://doi.org/10.1038/s41591-021-01372-z
Publication status	Published - Jun 2021

Bibliographical note

Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature America, Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41591-021-01372-z

Fingerprint

Dive into the research topics of 'Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (Nature Medicine, (2021), 27, 2, (279-288), 10.1038/s41591-020-01179-4)'. Together they form a unique fingerprint.

Cite this

@article{268feac0c79e47cc8efda75a6055c754,

title = "Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (Nature Medicine, (2021), 27, 2, (279-288), 10.1038/s41591-020-01179-4)",

abstract = "In the version of this article initially published, the numbers of cells in the third sentence of the second paragraph of the Methods subsection {\textquoteleft}Antibody-dependent neutrophil phagocytosis{\textquoteright} (500,000) and in the fifth sentence of the first paragraph of the Methods subsection {\textquoteleft}Antibody-dependent monocyte phagocytosis{\textquoteright} (250,000) were incorrect. The correct numbers are 50,000 and 25,000 (respectively). The errors have been corrected in the HTML and PDF versions of the article. *A full list of authors and their affiliations appears at the end of the paper.",

author = "{the Oxford COVID Vaccine Trial Group} and Barrett, {Jordan R.} and Sandra Belij-Rammerstorfer and Christina Dold and Ewer, {Katie J.} and Folegatti, {Pedro M.} and Ciaran Gilbride and Rachel Halkerston and Jennifer Hill and Daniel Jenkin and Lisa Stockdale and Verheul, {Marije K.} and Aley, {Parvinder K.} and Brian Angus and Duncan Bellamy and Eleanor Berrie and Sagida Bibi and Mustapha Bittaye and Miles Carroll and Breeze Cavell and Clutterbuck, {Elizabeth A.} and Nick Edwards and Amy Flaxman and Michelle Fuskova and Andrew Gorringe and Bassam Hallis and Simon Kerridge and Lawrie, {Alison M.} and Aline Linder and Xinxue Liu and Meera Madhavan and Rebecca Makinson and Jack Mellors and Angela Minassian and Maria Moore and Yama Mujadidi and Emma Plested and Ian Poulton and Ramasamy, {Maheshi N.} and Stephen Taylor and Kelly Thomas and Lauren Allen and Kevin Bewley and Karen Buttigieg and Naomi Coombes and Michael Elmore and Kerry Godwin and Holly Humphries and Lorna McInroy and Imam Shaik and Julia Tree",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer Nature America, Inc.",

year = "2021",

month = jun,

doi = "10.1038/s41591-021-01372-z",

language = "English",

volume = "27",

pages = "1113",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "6",

}

TY - JOUR

T1 - Author Correction

T2 - Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (Nature Medicine, (2021), 27, 2, (279-288), 10.1038/s41591-020-01179-4)

AU - the Oxford COVID Vaccine Trial Group

AU - Barrett, Jordan R.

AU - Belij-Rammerstorfer, Sandra

AU - Dold, Christina

AU - Ewer, Katie J.

AU - Folegatti, Pedro M.

AU - Gilbride, Ciaran

AU - Halkerston, Rachel

AU - Hill, Jennifer

AU - Jenkin, Daniel

AU - Stockdale, Lisa

AU - Verheul, Marije K.

AU - Aley, Parvinder K.

AU - Angus, Brian

AU - Bellamy, Duncan

AU - Berrie, Eleanor

AU - Bibi, Sagida

AU - Bittaye, Mustapha

AU - Carroll, Miles

AU - Cavell, Breeze

AU - Clutterbuck, Elizabeth A.

AU - Edwards, Nick

AU - Flaxman, Amy

AU - Fuskova, Michelle

AU - Gorringe, Andrew

AU - Hallis, Bassam

AU - Kerridge, Simon

AU - Lawrie, Alison M.

AU - Linder, Aline

AU - Liu, Xinxue

AU - Madhavan, Meera

AU - Makinson, Rebecca

AU - Mellors, Jack

AU - Minassian, Angela

AU - Moore, Maria

AU - Mujadidi, Yama

AU - Plested, Emma

AU - Poulton, Ian

AU - Ramasamy, Maheshi N.

AU - Taylor, Stephen

AU - Thomas, Kelly

AU - Allen, Lauren

AU - Bewley, Kevin

AU - Buttigieg, Karen

AU - Coombes, Naomi

AU - Elmore, Michael

AU - Godwin, Kerry

AU - Humphries, Holly

AU - McInroy, Lorna

AU - Shaik, Imam

AU - Tree, Julia

PY - 2021/6

Y1 - 2021/6

N2 - In the version of this article initially published, the numbers of cells in the third sentence of the second paragraph of the Methods subsection ‘Antibody-dependent neutrophil phagocytosis’ (500,000) and in the fifth sentence of the first paragraph of the Methods subsection ‘Antibody-dependent monocyte phagocytosis’ (250,000) were incorrect. The correct numbers are 50,000 and 25,000 (respectively). The errors have been corrected in the HTML and PDF versions of the article. *A full list of authors and their affiliations appears at the end of the paper.

AB - In the version of this article initially published, the numbers of cells in the third sentence of the second paragraph of the Methods subsection ‘Antibody-dependent neutrophil phagocytosis’ (500,000) and in the fifth sentence of the first paragraph of the Methods subsection ‘Antibody-dependent monocyte phagocytosis’ (250,000) were incorrect. The correct numbers are 50,000 and 25,000 (respectively). The errors have been corrected in the HTML and PDF versions of the article. *A full list of authors and their affiliations appears at the end of the paper.

UR - http://www.scopus.com/inward/record.url?scp=85105410526&partnerID=8YFLogxK

U2 - 10.1038/s41591-021-01372-z

DO - 10.1038/s41591-021-01372-z

M3 - Comment/debate

AN - SCOPUS:85105410526

SN - 1078-8956

VL - 27

SP - 1113

JO - Nature Medicine

JF - Nature Medicine

IS - 6

ER -

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (Nature Medicine, (2021), 27, 2, (279-288), 10.1038/s41591-020-01179-4)

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this